Advanced Accelerator Applications SA (NASDAQ:AAAP)‘s stock had its “buy” rating reissued by analysts at Jefferies Group in a report issued on Wednesday. They presently have a $45.00 target price on the stock. Jefferies Group’s price objective suggests a potential upside of 18.39% from the company’s previous close.

Separately, Zacks Investment Research raised shares of Advanced Accelerator Applications SA from a “hold” rating to a “buy” rating and set a $44.00 target price on the stock in a research report on Tuesday. One investment analyst has rated the stock with a hold rating and six have issued a buy rating to the company. The stock currently has a consensus rating of “Buy” and an average price target of $37.95.

Analyst Recommendations for Advanced Accelerator Applications SA (NASDAQ:AAAP)

Shares of Advanced Accelerator Applications SA (NASDAQ:AAAP) traded down 0.47% during trading on Wednesday, hitting $37.83. 17,448 shares of the company’s stock were exchanged. The stock’s market cap is $1.49 billion. Advanced Accelerator Applications SA has a one year low of $18.00 and a one year high of $39.66. The firm has a 50-day moving average price of $36.33 and a 200-day moving average price of $32.89.

Advanced Accelerator Applications SA (NASDAQ:AAAP) last released its earnings results on Wednesday, August 31st. The company reported ($0.04) earnings per share for the quarter, topping the consensus estimate of ($0.09) by $0.05. Advanced Accelerator Applications SA had a negative net margin of 12.87% and a negative return on equity of 8.50%. Equities research analysts expect that Advanced Accelerator Applications SA will post ($0.44) EPS for the current fiscal year.

Several hedge funds have recently added to or reduced their stakes in AAAP. FMR LLC increased its stake in Advanced Accelerator Applications SA by 153.9% in the second quarter. FMR LLC now owns 1,697,888 shares of the company’s stock valued at $51,336,000 after buying an additional 1,029,110 shares during the period. Vivo Capital LLC acquired a new stake in Advanced Accelerator Applications SA during the first quarter valued at approximately $15,962,000. Scopia Capital Management LP increased its stake in Advanced Accelerator Applications SA by 16.4% in the first quarter. Scopia Capital Management LP now owns 1,044,512 shares of the company’s stock valued at $36,579,000 after buying an additional 146,825 shares during the period. Royce & Associates LP acquired a new stake in Advanced Accelerator Applications SA during the second quarter valued at approximately $454,000. Finally, Alps Advisors Inc. increased its stake in Advanced Accelerator Applications SA by 27.2% in the second quarter. Alps Advisors Inc. now owns 55,178 shares of the company’s stock valued at $1,668,000 after buying an additional 11,796 shares during the period. 16.28% of the stock is currently owned by institutional investors and hedge funds.

About Advanced Accelerator Applications SA

Advanced Accelerator Applications SA is a radiopharmaceutical company that develops, produces and sells molecular nuclear medicine (MNM), diagnostic and therapeutic products. The Company’s lead therapeutic candidate, Lutathera, is being developed for the treatment of midgut neuroendocrine tumors (NETs).

5 Day Chart for NASDAQ:AAAP

Receive News & Stock Ratings for Advanced Accelerator Applications SA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advanced Accelerator Applications SA and related stocks with our FREE daily email newsletter.